Preliminary interim data of elzovantinib (TPX-0022), a novel inhibitor of MET/SRC/CSF1R, in patients with advanced solid tumors harboring genetic alterations in MET: Update from the Phase 1 SHIELD-1 trial

D. Hong; A. Shergill; L. Bazhenova; B. C. Cho; R. Heist; V. Moreno; G. S. Falchook; M. Nagasaka; P. Cassier; B. Besse; D. W. Kim; S. Yoon; X. Le; T. Zhao; S. Atwal; E. Park; J. Lee

doi:10.1016/S0959-8049(22)00992-3

Preliminary interim data of elzovantinib (TPX-0022), a novel inhibitor of MET/SRC/CSF1R, in patients with advanced solid tumors harboring genetic alterations in MET: Update from the Phase 1 SHIELD-1 trial

D. Hong, A. Shergill, L. Bazhenova, B. C. Cho, R. Heist, V. Moreno, G. S. Falchook, M. Nagasaka, P. Cassier, B. Besse, D. W. Kim, S. Yoon, X. Le, T. Zhao, S. Atwal, E. Park, J. Lee

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

langue originale	Anglais
Pages (de - à)	S72
journal	European Journal of Cancer
Volume	174
Les DOIs	https://doi.org/10.1016/S0959-8049(22)00992-3
état	Publié - 1 oct. 2022

Accès au document

10.1016/S0959-8049(22)00992-3

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

Hong, D., Shergill, A., Bazhenova, L., Cho, B. C., Heist, R., Moreno, V., Falchook, G. S., Nagasaka, M., Cassier, P., Besse, B., Kim, D. W., Yoon, S., Le, X., Zhao, T., Atwal, S., Park, E., & Lee, J. (2022). Preliminary interim data of elzovantinib (TPX-0022), a novel inhibitor of MET/SRC/CSF1R, in patients with advanced solid tumors harboring genetic alterations in MET: Update from the Phase 1 SHIELD-1 trial. European Journal of Cancer, 174, S72. https://doi.org/10.1016/S0959-8049(22)00992-3

@article{e2a4c545ae514b15bda477f7a60b5d82,

title = "Preliminary interim data of elzovantinib (TPX-0022), a novel inhibitor of MET/SRC/CSF1R, in patients with advanced solid tumors harboring genetic alterations in MET: Update from the Phase 1 SHIELD-1 trial",

author = "D. Hong and A. Shergill and L. Bazhenova and Cho, {B. C.} and R. Heist and V. Moreno and Falchook, {G. S.} and M. Nagasaka and P. Cassier and B. Besse and Kim, {D. W.} and S. Yoon and X. Le and T. Zhao and S. Atwal and E. Park and J. Lee",

year = "2022",

month = oct,

day = "1",

doi = "10.1016/S0959-8049(22)00992-3",

language = "English",

volume = "174",

pages = "S72",

journal = "European Journal of Cancer",

issn = "0959-8049",

}

Hong, D, Shergill, A, Bazhenova, L, Cho, BC, Heist, R, Moreno, V, Falchook, GS, Nagasaka, M, Cassier, P, Besse, B, Kim, DW, Yoon, S, Le, X, Zhao, T, Atwal, S, Park, E & Lee, J 2022, 'Preliminary interim data of elzovantinib (TPX-0022), a novel inhibitor of MET/SRC/CSF1R, in patients with advanced solid tumors harboring genetic alterations in MET: Update from the Phase 1 SHIELD-1 trial', European Journal of Cancer, VOL. 174, p. S72. https://doi.org/10.1016/S0959-8049(22)00992-3

Preliminary interim data of elzovantinib (TPX-0022), a novel inhibitor of MET/SRC/CSF1R, in patients with advanced solid tumors harboring genetic alterations in MET: Update from the Phase 1 SHIELD-1 trial. / Hong, D.; Shergill, A.; Bazhenova, L. et al.
Dans: European Journal of Cancer, Vol 174, 01.10.2022, p. S72.

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

TY - JOUR

T1 - Preliminary interim data of elzovantinib (TPX-0022), a novel inhibitor of MET/SRC/CSF1R, in patients with advanced solid tumors harboring genetic alterations in MET

T2 - Update from the Phase 1 SHIELD-1 trial

AU - Hong, D.

AU - Shergill, A.

AU - Bazhenova, L.

AU - Cho, B. C.

AU - Heist, R.

AU - Moreno, V.

AU - Falchook, G. S.

AU - Nagasaka, M.

AU - Cassier, P.

AU - Besse, B.

AU - Kim, D. W.

AU - Yoon, S.

AU - Le, X.

AU - Zhao, T.

AU - Atwal, S.

AU - Park, E.

AU - Lee, J.

PY - 2022/10/1

Y1 - 2022/10/1

UR - http://www.scopus.com/inward/record.url?scp=85140474641&partnerID=8YFLogxK

U2 - 10.1016/S0959-8049(22)00992-3

DO - 10.1016/S0959-8049(22)00992-3

M3 - Article

AN - SCOPUS:85140474641

SN - 0959-8049

VL - 174

SP - S72

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -